“…Subsequently, the recovery of p97 from its inhibitor, at the same time when newly-synthesized proteins were blocked by CHX, rendered portion of the existing ER-resident protein V5-N298-eGFP to be dynamically dislocated into the extra-luminal cytoplasmic side of membranes, in which it was allowed for the successive proteolytic digestion by 26S proteasomes and/or cleavage by other proteases through potential degrons and cleavage sites within N298. Just so a recovery of p97 from its inhibition by NMS-873 led to the release of the existing V5-N298-eGFP, subsequent turnover of its full-length ~80-kDa protein, together with its derived N-terminal polypeptides of ~55-kDa and ~12.5-kDa ( Figure 6C, lanes [5][6][7][8], was determined with their distinct half-lives estimated to be 3.25, 2.74 and 3.18 h after treatment with CHX, respectively (right graphic). By contrast, addition of MG132 (at 5 mol/L) differentially prolonged the half-lives of the ~80-kDa V5-N298-eGFP, as well as its N-terminal ~55-kDa and ~12.5-kDa polypeptides to 4.0, 3.10 and 3.34 h following CHX treatment, respectively ( Figure 6C, lanes 9-12, left graphic).…”